Defibrillation is a common treatment for life-threatening cardiac dysrhythmias, ventricular fibrillation and pulseless ventricular tachycardia. Defibrillation consists of delivering a therapeutic dose of electrical energy to the heart with a device called a defibrillator. This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia and allows normal sinus rhythm to be reestablished by the body's natural pacemaker, in the sinoatrial node of the heart. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. Some external units, known as automated external defibrillators (AEDs), automate the diagnosis of treatable rhythms, meaning that lay responders or bystanders are able to use them successfully with little or no training at all.
Figure Defibrillator Product Picture
Over the past decade, the global defibrillator industry has witnessed remarkable growth. And it is forecasted that the market will continue to grow at a speed over 5% in the following decade. The major drivers for the market include the development of technologically advanced defibrillators, rapid growth in the aging population with high risk of target diseases, rising incidences of cardiovascular diseases across the globe, growing focus of public and private organizations and key market players toward public access defibrillation, and increasing number of training and awareness programs across the globe.
Currently, North America is the largest market of defibrillator worldwide, owing to the growing prevalence of cardiovascular disorders. Europe is the second largest market, and followed by Asia Pacific.
According to our research and analysis, the leading five companies in the market occupies about 65% of the production value shares. Major manufacturers in the market are Medtronic, St. Jude, Medical, Boston Scientific, Biotronik and Physio-Control.
Implantable cardioverter defibrillators and external defibrillators are the two main products segments of defibrillator. ICD was the largest product segment. The possibility of remote patient monitoring by the utility of this device, is a major driver of the segment. New generation ICD with the bi-functional capability of preventing cardiac arrest along with performing the role of a pacemaker are expected to enhance sales volume of the device. External defibrillators are the second largest product segment. The ability of the device to diagnose early onset of ventricular tachycardia and ventricular defibrillation is expected to promote their demand.
Although sales of defibrillator brought a lot of opportunities, the study group recommends the new entrants just having money but without technical advantage and downstream support do not to enter into the defibrillator field.
According to this study, over the next five years the Defibrillator market will register a xx% CAGR in terms of revenue, the global market size will reach USD xx million by 2024, from USD xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Defibrillator business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Defibrillator market by product type, application, key manufacturers and key regions and countries.
This study considers the Defibrillator value and volume generated from the sales of the following segments-
Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Automatic External Defibrillators
Implantable Cardioverter Defibrillators
Wearable Cardioverter Defibrillator
Advanced Life Support (ALS)
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Public Access
Home Healthcare
Other
This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Medtronic
St. Jude Medical
Boston Scientific
Biotronik
Physio-Control
Nihon Kohden Corporation
Zoll Medical
Cardiac Science
Philips Healthcare
PRIMEDIC
Schiller
Sorin Group
HeartSine Technologies
Defibtech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Defibrillator consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Defibrillator market by identifying its various subsegments.
Focuses on the key global Defibrillator manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Defibrillator with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Defibrillator submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
